SBBP - Strongbridge Biopharma plc (SBBP) CEO John Johnson on Q1 2021 Results - Earnings Call Transcript

Strongbridge Biopharma plc (SBBP) Q1 2021 Earnings Conference Call May 12, 2021, 08:30 AM ET Company Participants Lindsay Rocco - Elixir Health, Public Relations John Johnson - CEO Fredric Cohen - CMO Richard Kollender - President and CFO Scott Wilhoit - CCO Officer Conference Call Participants Roger Song - Jefferies Annabel Samimy - Stifel Jonathan Wolleben - JMP Securities Robin Garner - Craig-Hallum Presentation Operator Good morning ladies and gentlemen and welcome to the Strongbridge Biopharma Plc Corporate Update and Q1 2021 Earnings Conference Call. At this time, all participants are in a listen only mode. [Operator Instructions] As a reminder this conference call is being recorded. I would now like to turn the conference over to your host, Lindsay Rocco, of Elixir Health, Public Relations. Lindsay Rocco Thank you and good afternoon, everyone. We are pleased that you could join us today for Strongbridge Biopharma’s first quarter 2021 earnings

For further details see:

Strongbridge Biopharma plc (SBBP) CEO John Johnson on Q1 2021 Results - Earnings Call Transcript